Log in to save to my catalogue

Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy

Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5023bc2c3db24738aa8011a1958cab2d

Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy

About this item

Full title

Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-05, Vol.13 (1), p.2425-20, Article 2425

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Limited substrates content is a major hurdle dampening the antitumor effect of catalytic therapy. Herein, a two-dimensional interplanar heterojunction (FeOCl/FeOOH NSs) with ·OH generation under ultrasound irradiation is fabricated and utilized for catalytic cancer therapy. This interplanar heterojunction is prepared through replacing chlorine from...

Alternative Titles

Full title

Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5023bc2c3db24738aa8011a1958cab2d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5023bc2c3db24738aa8011a1958cab2d

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-30166-1

How to access this item